These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21486967)

  • 1. 10-year national vaccine plan aims to harness new technology, enhance safety.
    Kuehn BM
    JAMA; 2011 Apr; 305(14):1399-400. PubMed ID: 21486967
    [No Abstract]   [Full Text] [Related]  

  • 2. Preface to supplement. Active surveillance of vaccine safety in the US Food and Drug Administration's Mini-Sentinel program: identification of exposures and outcomes.
    Vaccine; 2013 Dec; 31 Suppl 10():K1. PubMed ID: 24331068
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
    Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
    Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Apr; 37(13):197-200. PubMed ID: 2832717
    [No Abstract]   [Full Text] [Related]  

  • 5. Leads from the MMWR. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination.
    JAMA; 1988 May; 259(17):2527-8. PubMed ID: 2833628
    [No Abstract]   [Full Text] [Related]  

  • 6. A plea for clear language on vaccine safety.
    MacDonald N; Picard A
    CMAJ; 2009 Mar; 180(7):E2-3, 697-8. PubMed ID: 19332737
    [No Abstract]   [Full Text] [Related]  

  • 7. How can you promote vaccine safety?
    Miller ER; Iskander J; Pickering S; Varricchio F
    Nursing; 2007 Apr; 37(4):58-63; quiz 63-4. PubMed ID: 17413371
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccine safety: current systems and recent findings.
    Wharton M
    Curr Opin Pediatr; 2010 Feb; 22(1):88-93. PubMed ID: 19952750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring and assessing vaccine safety: a European perspective.
    Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
    Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.
    Nguyen M; Ball R; Midthun K; Lieu TA
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():291-7. PubMed ID: 22262619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the future of postmarket vaccine safety surveillance and evaluation.
    Ball R
    Expert Rev Vaccines; 2014 Apr; 13(4):455-62. PubMed ID: 24606417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear language.
    Finley GA
    CMAJ; 2009 Jun; 180(13):1330. PubMed ID: 19546461
    [No Abstract]   [Full Text] [Related]  

  • 13. Clear language.
    Arya SC; Agarwal N
    CMAJ; 2009 Jun; 180(13):1330. PubMed ID: 19546460
    [No Abstract]   [Full Text] [Related]  

  • 14. Technologies that make administration of vaccines safer.
    Clements CJ; Larsen G; Jodar L
    Vaccine; 2004 May; 22(15-16):2054-8. PubMed ID: 15121322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Vaccine Safety Datalink: a model for monitoring immunization safety.
    Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
    Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods in vaccine effectiveness and safety studies: a critical need for vaccine confidence.
    Jacobsen SJ; Poland GA
    Vaccine; 2011 Dec; 29(52):9573-4. PubMed ID: 22051135
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program.
    Lieu TA; Nguyen MD; Ball R; Martin DB
    Vaccine; 2012 Apr; 30(18):2824-30. PubMed ID: 22394993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012.
    Mayet A; Duron S; Meynard JB; Koeck JL; Deparis X; Migliani R
    Public Health; 2015 Jun; 129(6):763-8. PubMed ID: 25890634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.